What FDA's Webinar on 21 CFR Part 111 Means for Your Supplement Brand
By Jake, founder · Published · Source dated
FDA's webinar offers insights on 21 CFR Part 111, focusing on finished product specifications and compliance risks for dietary supplement brands.
What Changed?
The FDA webinar on 21 CFR Part 111 did not introduce new regulations but provided detailed insights into existing rules. It focused on the importance of establishing and meeting finished product specifications. The webinar aimed to help manufacturers and brands better understand these requirements within the broader context of a compliant dietary supplement quality system.
Who Does It Apply To?
This webinar is particularly relevant for dietary supplement manufacturers and brands that sell on platforms like Amazon. It offers practical guidance on how to establish and meet finished product specifications under 21 CFR Part 111. While the webinar is geared towards those involved in manufacturing, Compliant Always can benefit by understanding the expectations set forth by FDA.
What Does It Not Say?
The webinar did not address specific actions Compliant Always must take beyond understanding the importance of finished product specifications. It also did not provide detailed steps for non-manufacturing brands on how to ensure their contract manufacturers comply with these specifications. The focus was primarily on the manufacturer's perspective.
Timelines and Dates
The webinar took place on August 14, 2026. There were no new deadlines or timelines introduced. However, the insights shared could help Compliant Always stay ahead of potential future FDA inspections or compliance checks by ensuring their finished product specifications are robust and well-documented.
What Should Compliant Always Do Now?
We suggest Compliant Always consider attending similar webinars or reviewing the content if available. Understanding the FDA's perspective on finished product specifications can be a sensible step. Compliant Always might also want to review their current quality agreements with contract manufacturers to ensure alignment with the principles discussed in the webinar.
Impact on Document Reviewers
Document reviewers may look more closely at finished product specifications after this webinar. They could expect more detailed documentation showing how these specifications were established and verified. Compliant Always should ensure their compliance documents reflect this level of detail to avoid potential issues.
Frequently asked questions
- Is there a cost to attend the webinar?
- NPA members can attend for free, while non-members pay $100. Consider membership for access to such resources.
- Can I sponsor the webinar?
- Yes, sponsorship costs $5,000 and includes logo placement and recognition. Contact ereinson@npanational.org for details.
- Will the webinar cover all aspects of 21 CFR Part 111?
- No, it focuses specifically on finished product specifications and related compliance risks.
- How can I prepare for the webinar?
- Review your current finished product specifications and quality agreements. Be ready to ask specific questions during the Q&A session.
Related guides
Sources
- Industry press — FDA Deep Dive Into CGMPs accessed 2026-09-06
Written from the source text above and checked against it before publishing: every date, figure and section cited appears in the source. Information, not legal advice.